Synthesis and human telomerase inhibition of a series of regioisomeric disubstituted amidoanthraquinones

Hsu Shan Huang, In Been Chen, Kuo Feng Huang, Wei Chih Lu, Fu Ying Shieh, Yi Yuan Huang, Fong Chun Huang, Jing J. Lin

Research output: Contribution to journalArticle

32 Citations (Scopus)

Abstract

Telomerase is the enzymatic activity that maintains the ends of eukaryotic chromosomes. Telomerase activity is detected in most tumor cells whereas it is low or undetectable in most normal somatic cells. Expression of the telomerase catalytic component, the human telomerase reverse transcriptase (hTERT), is believed to be controlled primarily at the level of transcription. Because of this selective expression property of telomerase, it has been touted as a specific target for antitumor chemotherapeutics. However, a concern for the applicability of telomerase inhibitors is that they require a long lag time for telomeres to be shortened to critical length before cancer cells stop proliferating. Here we investigate telomerase inhibitory, cytotoxicity and the hTERT repressing effects on a number of synthesized 2,6-diamidoanthraquinones and 1,5-diamidoanthraquinones as compared to their disubstituted homologues. We found that several of the 1,5-diamidoanthraquinones and 2,6- diamidoanthraquinones inhibited telomerase activity effectively with IC 50 at the sub-micro to micro molar range and caused acute cytotoxicity to cancer cells with EC50 similar or better than that of mitoxantrone. Particularly, 2,6-diamidoanthraquinone with 2-ethylaminoacetamido side chains 33, even though not affecting cell proliferation, showed to be endowed with a strong telomerase effect, probably related to a marked stabilization of the G-quadruplex-binding structure. The results suggested that these compounds caused multiple effects to cancer cells. More significantly, they overcome the long lag period problem of classical telomerase inhibitors that they are also potent cytotoxic agents. These results greatly expand the potential of tricyclic anthraquinone pharmacophore in preventive and/or curative therapy.

Original languageEnglish
Pages (from-to)284-292
Number of pages9
JournalChemical and Pharmaceutical Bulletin
Volume55
Issue number2
DOIs
Publication statusPublished - Feb 2007
Externally publishedYes

Fingerprint

Telomerase
Cells
Cytotoxicity
Neoplasms
G-Quadruplexes
Anthraquinones
Mitoxantrone
Telomere
Cytotoxins
Cell proliferation
Transcription
Chromosomes
Tumors
Stabilization
Cell Proliferation

Keywords

  • Anthraquinone
  • Cytotoxicity
  • G-quadruplex
  • Human telomerase reverse transcriptase (hTERT)
  • Secreted alkaline phosphatase (SEAP) assay
  • Telomerase assay
  • Telomerase inhibition
  • TRAP assay

ASJC Scopus subject areas

  • Chemistry(all)
  • Organic Chemistry
  • Drug Discovery
  • Pharmacology

Cite this

Synthesis and human telomerase inhibition of a series of regioisomeric disubstituted amidoanthraquinones. / Huang, Hsu Shan; Chen, In Been; Huang, Kuo Feng; Lu, Wei Chih; Shieh, Fu Ying; Huang, Yi Yuan; Huang, Fong Chun; Lin, Jing J.

In: Chemical and Pharmaceutical Bulletin, Vol. 55, No. 2, 02.2007, p. 284-292.

Research output: Contribution to journalArticle

Huang, Hsu Shan ; Chen, In Been ; Huang, Kuo Feng ; Lu, Wei Chih ; Shieh, Fu Ying ; Huang, Yi Yuan ; Huang, Fong Chun ; Lin, Jing J. / Synthesis and human telomerase inhibition of a series of regioisomeric disubstituted amidoanthraquinones. In: Chemical and Pharmaceutical Bulletin. 2007 ; Vol. 55, No. 2. pp. 284-292.
@article{d665927ab92a447f8595f7ff88b0ae04,
title = "Synthesis and human telomerase inhibition of a series of regioisomeric disubstituted amidoanthraquinones",
abstract = "Telomerase is the enzymatic activity that maintains the ends of eukaryotic chromosomes. Telomerase activity is detected in most tumor cells whereas it is low or undetectable in most normal somatic cells. Expression of the telomerase catalytic component, the human telomerase reverse transcriptase (hTERT), is believed to be controlled primarily at the level of transcription. Because of this selective expression property of telomerase, it has been touted as a specific target for antitumor chemotherapeutics. However, a concern for the applicability of telomerase inhibitors is that they require a long lag time for telomeres to be shortened to critical length before cancer cells stop proliferating. Here we investigate telomerase inhibitory, cytotoxicity and the hTERT repressing effects on a number of synthesized 2,6-diamidoanthraquinones and 1,5-diamidoanthraquinones as compared to their disubstituted homologues. We found that several of the 1,5-diamidoanthraquinones and 2,6- diamidoanthraquinones inhibited telomerase activity effectively with IC 50 at the sub-micro to micro molar range and caused acute cytotoxicity to cancer cells with EC50 similar or better than that of mitoxantrone. Particularly, 2,6-diamidoanthraquinone with 2-ethylaminoacetamido side chains 33, even though not affecting cell proliferation, showed to be endowed with a strong telomerase effect, probably related to a marked stabilization of the G-quadruplex-binding structure. The results suggested that these compounds caused multiple effects to cancer cells. More significantly, they overcome the long lag period problem of classical telomerase inhibitors that they are also potent cytotoxic agents. These results greatly expand the potential of tricyclic anthraquinone pharmacophore in preventive and/or curative therapy.",
keywords = "Anthraquinone, Cytotoxicity, G-quadruplex, Human telomerase reverse transcriptase (hTERT), Secreted alkaline phosphatase (SEAP) assay, Telomerase assay, Telomerase inhibition, TRAP assay",
author = "Huang, {Hsu Shan} and Chen, {In Been} and Huang, {Kuo Feng} and Lu, {Wei Chih} and Shieh, {Fu Ying} and Huang, {Yi Yuan} and Huang, {Fong Chun} and Lin, {Jing J.}",
year = "2007",
month = "2",
doi = "10.1248/cpb.55.284",
language = "English",
volume = "55",
pages = "284--292",
journal = "Chemical and Pharmaceutical Bulletin",
issn = "0009-2363",
publisher = "Pharmaceutical Society of Japan",
number = "2",

}

TY - JOUR

T1 - Synthesis and human telomerase inhibition of a series of regioisomeric disubstituted amidoanthraquinones

AU - Huang, Hsu Shan

AU - Chen, In Been

AU - Huang, Kuo Feng

AU - Lu, Wei Chih

AU - Shieh, Fu Ying

AU - Huang, Yi Yuan

AU - Huang, Fong Chun

AU - Lin, Jing J.

PY - 2007/2

Y1 - 2007/2

N2 - Telomerase is the enzymatic activity that maintains the ends of eukaryotic chromosomes. Telomerase activity is detected in most tumor cells whereas it is low or undetectable in most normal somatic cells. Expression of the telomerase catalytic component, the human telomerase reverse transcriptase (hTERT), is believed to be controlled primarily at the level of transcription. Because of this selective expression property of telomerase, it has been touted as a specific target for antitumor chemotherapeutics. However, a concern for the applicability of telomerase inhibitors is that they require a long lag time for telomeres to be shortened to critical length before cancer cells stop proliferating. Here we investigate telomerase inhibitory, cytotoxicity and the hTERT repressing effects on a number of synthesized 2,6-diamidoanthraquinones and 1,5-diamidoanthraquinones as compared to their disubstituted homologues. We found that several of the 1,5-diamidoanthraquinones and 2,6- diamidoanthraquinones inhibited telomerase activity effectively with IC 50 at the sub-micro to micro molar range and caused acute cytotoxicity to cancer cells with EC50 similar or better than that of mitoxantrone. Particularly, 2,6-diamidoanthraquinone with 2-ethylaminoacetamido side chains 33, even though not affecting cell proliferation, showed to be endowed with a strong telomerase effect, probably related to a marked stabilization of the G-quadruplex-binding structure. The results suggested that these compounds caused multiple effects to cancer cells. More significantly, they overcome the long lag period problem of classical telomerase inhibitors that they are also potent cytotoxic agents. These results greatly expand the potential of tricyclic anthraquinone pharmacophore in preventive and/or curative therapy.

AB - Telomerase is the enzymatic activity that maintains the ends of eukaryotic chromosomes. Telomerase activity is detected in most tumor cells whereas it is low or undetectable in most normal somatic cells. Expression of the telomerase catalytic component, the human telomerase reverse transcriptase (hTERT), is believed to be controlled primarily at the level of transcription. Because of this selective expression property of telomerase, it has been touted as a specific target for antitumor chemotherapeutics. However, a concern for the applicability of telomerase inhibitors is that they require a long lag time for telomeres to be shortened to critical length before cancer cells stop proliferating. Here we investigate telomerase inhibitory, cytotoxicity and the hTERT repressing effects on a number of synthesized 2,6-diamidoanthraquinones and 1,5-diamidoanthraquinones as compared to their disubstituted homologues. We found that several of the 1,5-diamidoanthraquinones and 2,6- diamidoanthraquinones inhibited telomerase activity effectively with IC 50 at the sub-micro to micro molar range and caused acute cytotoxicity to cancer cells with EC50 similar or better than that of mitoxantrone. Particularly, 2,6-diamidoanthraquinone with 2-ethylaminoacetamido side chains 33, even though not affecting cell proliferation, showed to be endowed with a strong telomerase effect, probably related to a marked stabilization of the G-quadruplex-binding structure. The results suggested that these compounds caused multiple effects to cancer cells. More significantly, they overcome the long lag period problem of classical telomerase inhibitors that they are also potent cytotoxic agents. These results greatly expand the potential of tricyclic anthraquinone pharmacophore in preventive and/or curative therapy.

KW - Anthraquinone

KW - Cytotoxicity

KW - G-quadruplex

KW - Human telomerase reverse transcriptase (hTERT)

KW - Secreted alkaline phosphatase (SEAP) assay

KW - Telomerase assay

KW - Telomerase inhibition

KW - TRAP assay

UR - http://www.scopus.com/inward/record.url?scp=33846954426&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33846954426&partnerID=8YFLogxK

U2 - 10.1248/cpb.55.284

DO - 10.1248/cpb.55.284

M3 - Article

C2 - 17268103

AN - SCOPUS:33846954426

VL - 55

SP - 284

EP - 292

JO - Chemical and Pharmaceutical Bulletin

JF - Chemical and Pharmaceutical Bulletin

SN - 0009-2363

IS - 2

ER -